Online Program

WHO safe childbirth checklist program: Designed to save maternal and newborn lives

Monday, November 4, 2013 : 9:20 a.m. - 9:35 a.m.

Jonathan Spector, Novartis Institutes for BioMedical Research, Cambridge, MA
The WHO Safe Childbirth Checklist Program was designed to save maternal and newborn lives by helping health workers in low-income countries to remember to conduct essential practices linked with improved childbirth outcomes.

The program was developed by WHO in collaboration with Harvard School of Public Health and a global network of frontline workers and other experts in maternal-newborn health.

The checklist itself is a 29-item tool focused on 4 major causes of maternal deaths (bleeding, infection, hypertension, and obstructed labor) and 3 major causes of newborn deaths (infection, prematurity, and intrapartum-related events).

Pilot testing in south India demonstrated highly significant improvement in health worker practices after rollout of the checklist program. Large-scale testing is currently underway in two states in north India, and WHO is making the checklist program available to research collaborators interested in further assessing how best this program can measurably strengthen health systems in real world settings.

Learning Areas:

Administer health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related research

Learning Objectives:
Describe the rationale for development of the WHO Safe Childbirth Checklist Program. Describe challenges associated with implementing maternal-newborn health systems solutions in high priority settings

Keyword(s): Maternal and Child Health, Infant Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been the principal on multiple grants focused on this work.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.